Chen J , Budoff MJ , Reilly MP , et al . Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease . JAMA Cardiol 2017 ; 2 ( 6 ): 635 - 43 . doi: 10.1001/jamacardio.2017.0363 http://dx.doi.org/10.1001/jamacardio.2017.0363 .

Rocha-Singh KJ , Zeller T , Jaff MR . Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications . Catheter Cardiovasc Interv 2014 ; 83 ( 6 ): E212 - 20 . doi: 10.1002/ccd.25387 http://dx.doi.org/10.1002/ccd.25387 .

Nigwekar SU , Thadhani R , Brandenburg VM . Calciphylaxis . N Engl J Med 2018 ; 378 ( 18 ): 1704 - 14 . doi: 10.1056/NEJMra1505292 http://dx.doi.org/10.1056/NEJMra1505292 .

Shen G , Huang R , Liu B , Kuang A . Sodium thiosulfate in the treatment of lung and breast calciphylaxis: CT and bone scintigraphy findings . Clin Nucl Med 2017 ; 42 ( 11 ): 893 - 5 . doi: 10.1097/RLU.0000000000001837 http://dx.doi.org/10.1097/RLU.0000000000001837 .

Kang SJW , Madhan K . Gastrointestinal manifestations in a patient with calciphylaxis: A case report . Case Rep Nephrol Dial 2019 ; 9 ( 2 ): 119 - 25 . doi: 10.1159/000502436 http://dx.doi.org/10.1159/000502436 .

Lahtinen AM , Havulinna AS , Jula A , et al . Prevalence and clinical correlates of familial hypercholesterolemia founder mutations in the general population . Atherosclerosis 2015 ; 238 ( 1 ): 64 - 9 . doi: 10.1016/j.atherosclerosis.2014.11.015 http://dx.doi.org/10.1016/j.atherosclerosis.2014.11.015 .

Wang J , Zhou JJ , Robertson GR , et al . Vitamin D in vascular calcification: a double-edged sword? Nutrients 2018 ; 10 ( 5 ). doi: 10.3390/nu10050652 http://dx.doi.org/10.3390/nu10050652 .

Shobeiri N , Adams MA , Holden RM . Vascular calcification in animal models of CKD: a review . Am J Nephrol 2010 ; 31 ( 6 ): 471 - 81 . doi: 10.1159/000299794 http://dx.doi.org/10.1159/000299794 .

Norman PE , Powell JT . Vitamin D and cardiovascular disease . Circ Res 2014 ; 114 ( 2 ): 379 - 93 . doi: 10.1161/CIRCRESAHA.113.301241 http://dx.doi.org/10.1161/CIRCRESAHA.113.301241 .

Shroff R , Egerton M , Bridel M , et al . A bimodal association of vitamin D levels and vascular disease in children on dialysis . J Am Soc Nephrol 2008 ; 19 ( 6 ): 1239 - 46 . doi: 10.1681/ASN.2007090993 http://dx.doi.org/10.1681/ASN.2007090993 .

Shioi A , Morioka T , Shoji T , et al . The inhibitory roles of vitamin K in progression of vascular calcification . Nutrients 2020 ; 12 ( 2 ). doi: 10.3390/nu12020583 http://dx.doi.org/10.3390/nu12020583 .

Halder M , Petsophonsakul P , Akbulut AC , et al . Vitamin K: double bonds beyond coagulation insights into differences between vitamin K1 and K2 in health and disease . Int J Mol Sci 2019 ; 20 ( 4 ). doi: 10.3390/ijms20040896 http://dx.doi.org/10.3390/ijms20040896 .

Wen L , Chen J , Duan L , et al . Vitamin K‑dependent proteins involved in bone and cardiovascular health (Review) . Mol Med Rep 2018 ; 18 ( 1 ): 3 - 15 . doi: 10.3892/mmr.2018.8940 http://dx.doi.org/10.3892/mmr.2018.8940 .

Hauschka PV , Lian JB , Cole DE , et al . Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone . Physiol Rev 1989 ; 69 ( 3 ): 990 - 1047 . doi: 10.1152/physrev.1989.69.3.990 http://dx.doi.org/10.1152/physrev.1989.69.3.990 .

Azuma K , Inoue S . Multiple modes of vitamin K actions in aging-related musculoskeletal disorders . Int J Mol Sci 2019 ; 20 ( 11 ). doi: 10.3390/ijms20112844 http://dx.doi.org/10.3390/ijms20112844 .

Viegas CS , Herfs M , Rafael MS , et al . Gla-rich protein is a potential new vitamin K target in cancer: evidences for a direct GRP-mineral interaction . Biomed Res Int 2014 ; 2014 : 340216 . doi: 10.1155/2014/340216 http://dx.doi.org/10.1155/2014/340216 .

Pan MH , Maresz K , Lee PS , et al . Inhibition of TNF-alpha, IL-1alpha, and IL-1beta by pretreatment of human monocyte-derived macrophages with menaquinone-7 and cell activation with TLR agonists in vitro . J Med Food 2016 ; 19 ( 7 ): 663 - 9 . doi: 10.1089/jmf.2016.0030 http://dx.doi.org/10.1089/jmf.2016.0030 .

Shea MK , Booth SL , Massaro JM , et al . Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study . Am J Epidemiol 2008 ; 167 ( 3 ): 313 - 20 . doi: 10.1093/aje/kwm306 http://dx.doi.org/10.1093/aje/kwm306 .

Shea MK , Dallal GE , Dawson-Hughes B , et al . Vitamin K, circulating cytokines, and bone mineral density in older men and women . Am J Clin Nutr 2008 ; 88 ( 2 ): 356 - 63 . doi: 10.1093/ajcn/88.2.356 http://dx.doi.org/10.1093/ajcn/88.2.356 .

Diederichsen ACP , Lindholt JS , Moller S , et al . Vitamin K2 and D in patients with aortic valve calcification: a randomized double-blinded clinical trial . Circulation 2022 ; 145 ( 18 ): 1387 - 97 . doi: 10.1161/CIRCULATIONAHA.121.057008 http://dx.doi.org/10.1161/CIRCULATIONAHA.121.057008 .

Lees JS , Rankin AJ , Gillis KA , et al . The ViKTORIES trial: a randomized, double-blind, placebo-controlled trial of vitamin K supplementation to improve vascular health in kidney transplant recipients . Am J Transplant 2021 ; 21 ( 10 ): 3356 - 68 . doi: 10.1111/ajt.16566 http://dx.doi.org/10.1111/ajt.16566 .

Ivanovski O , Szumilak D , Nguyen-Khoa T , et al . Effect of simvastatin in apolipoprotein E-deficient mice with surgically induced chronic renal failure . J Urol 2008 ; 179 ( 4 ): 1631 - 36 . doi: 10.1016/j.juro.2007.11.042 http://dx.doi.org/10.1016/j.juro.2007.11.042 .

Afonso P , Auclair M , Boccara F , et al . LMNA mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: role of ZMPSTE24 downregulation . Atherosclerosis 2016 ; 245 : 200 - 11 . doi: 10.1016/j.atherosclerosis.2015.12.012 http://dx.doi.org/10.1016/j.atherosclerosis.2015.12.012 .

Healy A , Berus JM , Christensen JL , et al . Statins disrupt macrophage rac1 regulation leading to increased atherosclerotic plaque calcification . Arterioscler Thromb Vasc Biol 2020 ; 40 ( 3 ): 714 - 32 . doi: 10.1161/ATVBAHA.119.313832 http://dx.doi.org/10.1161/ATVBAHA.119.313832 .

Son BK , Kozaki K , Iijima K , et al . Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells . Eur J Pharmacol 2007 ; 556 ( 1-3 ): 1 - 8 . doi: 10.1016/j.ejphar.2006.09.070 http://dx.doi.org/10.1016/j.ejphar.2006.09.070 .

Qiu C , Zheng H , Tao H , et al . Vitamin K2 inhibits rat vascular smooth muscle cell calcification by restoring the Gas6/Axl/Akt anti-apoptotic pathway . Mol Cell Biochem 2017 ; 433 ( 1-2 ): 149 - 59 . doi: 10.1007/s11010-017-3023-z http://dx.doi.org/10.1007/s11010-017-3023-z .

Dykun I , Lehmann N , Kalsch H , et al . Statin medication enhances progression of coronary artery calcification: the Heinz Nixdorf Recall Study . J Am Coll Cardiol 2016 ; 68 ( 19 ): 2123 - 5 . doi: 10.1016/j.jacc.2016.08.040 http://dx.doi.org/10.1016/j.jacc.2016.08.040 .

Vogel LH , Dykun I , Raggi P , et al . High- vs. low-intensity statin therapy and changes in coronary artery calcification density after one year . J Clin Med 2023 ; 12 ( 2 ). doi: 10.3390/jcm12020476 http://dx.doi.org/10.3390/jcm12020476 .

Hur DJ , Raymond GV , Kahler SG , et al . A novel MGP mutation in a consanguineous family: review of the clinical and molecular characteristics of Keutel syndrome . Am J Med Genet A 2005 ; 135 ( 1 ): 36 - 40 . doi: 10.1002/ajmg.a.30680 http://dx.doi.org/10.1002/ajmg.a.30680 .

O'Young J , Liao Y , Xiao Y , et al . Matrix Gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatite crystals . J Am Chem Soc 2011 ; 133 ( 45 ): 18406 - 12 . doi: 10.1021/ja207628k http://dx.doi.org/10.1021/ja207628k .

Zebboudj AF , Imura M , Bostrom K . Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2 . J Biol Chem 2002 ; 277 ( 6 ): 4388 - 94 . doi: 10.1074/jbc.M109683200 http://dx.doi.org/10.1074/jbc.M109683200 .

Spronk HM , Soute BA , Schurgers LJ , et al . Matrix Gla protein accumulates at the border of regions of calcification and normal tissue in the media of the arterial vessel wall . Biochem Biophys Res Commun 2001 ; 289 ( 2 ): 485 - 90 . doi: 10.1006/bbrc.2001.5996 http://dx.doi.org/10.1006/bbrc.2001.5996 .

Shioi A , Taniwaki H , Jono S , et al . Monckeberg's medial sclerosis and inorganic phosphate in uremia . Am J Kidney Dis 2001 ; 38 (4 Suppl 1 ): S47 - 49 . doi: 10.1053/ajkd.2001.27396 http://dx.doi.org/10.1053/ajkd.2001.27396 .

Ravindran S , Swaminathan K , Ramesh A , et al . Nicorandil attenuates neuronal mitochondrial dysfunction and oxidative stress associated with murine model of vascular calcification . Acta Neurobiol Exp (Wars) 2017 ; 77 ( 1 ): 57 - 67 . doi: 10.21307/ane-2017-036 http://dx.doi.org/10.21307/ane-2017-036 .

Ravindran S , Ramachandran K , Kurian GA . Sodium thiosulfate mediated cardioprotection against myocardial ischemia-reperfusion injury is defunct in rat heart with co-morbidity of vascular calcification . Biochimie 2018 ; 147 : 80 - 8 . doi: 10.1016/j.biochi.2018.01.004 http://dx.doi.org/10.1016/j.biochi.2018.01.004 .

Ravindran S , Murali J , Amirthalingam SK , et al . Vascular calcification abrogates the nicorandil mediated cardio-protection in ischemia reperfusion injury of rat heart . Vascul Pharmacol 2017 ; 89 : 31 - 8 . doi: 10.1016/j.vph.2016.12.004 http://dx.doi.org/10.1016/j.vph.2016.12.004 .

Zhu Y , Han XQ , Sun XJ , et al . Lactate accelerates vascular calcification through NR4A1-regulated mitochondrial fission and BNIP3-related mitophagy . Apoptosis 2020 , 25 : 321 - 40 . doi: 10.1007/s10495-020-01592-7 http://dx.doi.org/10.1007/s10495-020-01592-7 .

Patel L , Bernard LM , Elder GJ . Sevelamer versus calcium-based binders for treatment of hyperphosphatemia in CKD: a meta-analysis of randomized controlled trials . Clin J Am Soc Nephrol 2016 ; 11 ( 2 ): 232 - 44 . doi: 10.2215/CJN.06800615 http://dx.doi.org/10.2215/CJN.06800615 .

Raggi P , Chertow GM , Torres PU , et al . The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis . Nephrol Dial Transplant 2011 ; 26 ( 4 ): 1327 - 39 . doi: 10.1093/ndt/gfq725 http://dx.doi.org/10.1093/ndt/gfq725 .

Grases F , Simonet BM , Vucenik I , et al . Absorption and excretion of orally administered inositol hexaphosphate (IP(6) or phytate) in humans . Biofactors 2001 ; 15 ( 1 ): 53 - 61 . doi: 10.1002/biof.5520150105 http://dx.doi.org/10.1002/biof.5520150105 .

Lopez-Gonzalez AA , Grases F , Monroy N , et al . Protective effect of myo-inositol hexaphosphate (phytate) on bone mass loss in postmenopausal women . Eur J Nutr 2013 ; 52 ( 2 ): 717 - 26 . doi: 10.1007/s00394-012-0377-6 http://dx.doi.org/10.1007/s00394-012-0377-6 .

Joubert P , Ketteler M , Salcedo C , et al . Hypothesis: Phytate is an important unrecognised nutrient and potential intravenous drug for preventing vascular calcification . Med Hypotheses 2016 ; 94 : 89 - 92 . doi: 10.1016/j.mehy.2016.07.005 http://dx.doi.org/10.1016/j.mehy.2016.07.005 .

Ferrer MD , Perez MM , Canaves MM , et al . A novel pharmacodynamic assay to evaluate the effects of crystallization inhibitors on calcium phosphate crystallization in human plasma . Sci Rep 2017 ; 7 ( 1 ): 6858 . doi: 10.1038/s41598-017-07203-x http://dx.doi.org/10.1038/s41598-017-07203-x .

Perello J , Ferrer MD , Del Mar Perez M , et al . Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis . Br J Pharmacol 2020 ; 177 ( 19 ): 4400 - 15 . doi: 10.1111/bph.15163 http://dx.doi.org/10.1111/bph.15163 .

Perello J , Joubert PH , Ferrer MD , et al . First-time-in-human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification . Br J Clin Pharmacol 2018 ; 84 ( 12 ): 2867 - 76 . doi: 10.1111/bcp.13752 http://dx.doi.org/10.1111/bcp.13752 .

Raggi P , Bellasi A , Bushinsky D , et al . Slowing progression of cardiovascular calcification with snf472 in patients on hemodialysis: results of a randomized phase 2b study . Circulation 2020 ; 141 ( 9 ): 728 - 39 . doi: 10.1161/CIRCULATIONAHA.119.044195 http://dx.doi.org/10.1161/CIRCULATIONAHA.119.044195 .

Bushinsky DA , Raggi P , Bover J , et al . Effects of myo-inositol hexaphosphate (SNF472) on bone mineral density in patients receiving hemodialysis: an analysis of the randomized, placebo-controlled CaLIPSO Study . Clin J Am Soc Nephrol 2021 ; 16 ( 5 ): 736 - 45 . doi: 10.2215/CJN.16931020 http://dx.doi.org/10.2215/CJN.16931020 .

Brandenburg VM , Sinha S , Torregrosa JV , et al . Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis . J Nephrol 2019 ; 32 ( 5 ): 811 - 21 . doi: 10.1007/s40620-019-00631-0 http://dx.doi.org/10.1007/s40620-019-00631-0 .

Sinha S , Gould LJ , Nigwekar SU , et al . The CALCIPHYX study: a randomized, double-blind, placebo-controlled, phase 3 clinical trial of SNF472 for the treatment of calciphylaxis . Clin Kidney J 2022 ; 15 ( 1 ): 136 - 44 . doi: 10.1093/ckj/sfab117 http://dx.doi.org/10.1093/ckj/sfab117 .

Chao CT , Yeh HY , Tsai YT , et al . Natural and non-natural antioxidative compounds: potential candidates for treatment of vascular calcification . Cell Death Discov 2019 ; 5 : 145 . doi: 10.1038/s41420-019-0225-z http://dx.doi.org/10.1038/s41420-019-0225-z .

Zhou J , Wang H , Shen R , et al . Mitochondrial-targeted antioxidant MitoQ provides neuroprotection and reduces neuronal apoptosis in experimental traumatic brain injury possibly via the Nrf2-ARE pathway . Am J Transl Res 2018 ; 10 ( 6 ): 1887 - 99 .

Cui L , Zhou Q , Zheng X , et al . Mitoquinone attenuates vascular calcification by suppressing oxidative stress and reducing apoptosis of vascular smooth muscle cells via the Keap1/Nrf2 pathway . Free Radic Biol Med 2020 ; 161 : 23 - 31 . doi: 10.1016/j.freeradbiomed.2020.09.028 http://dx.doi.org/10.1016/j.freeradbiomed.2020.09.028 .

Rossman MJ , Santos-Parker JR , Steward CAC , et al . Chronic supplementation with a mitochondrial antioxidant (MitoQ) improves vascular function in healthy older adults . Hypertension 2018 ; 71 ( 6 ): 1056 - 63 . doi: 10.1161/HYPERTENSIONAHA.117.10787 http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.10787 .

Tharakan B , Holder-Haynes JG , Hunter FA , et al . Alpha lipoic acid attenuates microvascular endothelial cell hyperpermeability by inhibiting the intrinsic apoptotic signaling . Am J Surg 2008 ; 195 ( 2 ): 174 - 8 . doi: 10.1016/j.amjsurg.2007.09.028 http://dx.doi.org/10.1016/j.amjsurg.2007.09.028 .

Kim H , Kim HJ , Lee K , et al . Alpha-Lipoic acid attenuates vascular calcification via reversal of mitochondrial function and restoration of Gas6/Axl/Akt survival pathway . J Cell Mol Med 2012 ; 16 ( 2 ): 273 - 86 . doi: 10.1111/j.1582-4934.2011.01294.x http://dx.doi.org/10.1111/j.1582-4934.2011.01294.x .

Himmelfarb J , Ikizler TA , Ellis C , et al . Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial . J Am Soc Nephrol 2014 ; 25 ( 3 ): 623 - 33 . doi: 10.1681/ASN.2013050545 http://dx.doi.org/10.1681/ASN.2013050545 .

Safa J , Ardalan MR , Rezazadehsaatlou M , et al . Effects of alpha lipoic acid supplementation on serum levels of IL-8 and TNF-alpha in patient with ESRD undergoing hemodialysis . Int Urol Nephrol 2014 ; 46 ( 8 ): 1633 - 8 . doi: 10.1007/s11255-014-0688-z http://dx.doi.org/10.1007/s11255-014-0688-z .

Peng T , Zhuo L , Wang Y , et al . Systematic review of sodium thiosulfate in treating calciphylaxis in chronic kidney disease patients . Nephrology (Carlton) 2018 ; 23 ( 7 ): 669 - 75 . doi: 10.1111/nep.13081 http://dx.doi.org/10.1111/nep.13081 .

Zhong H , Liu F , Dai X , et al . Sodium thiosulfate protects human aortic smooth muscle cells from osteoblastic transdifferentiation via high-level phosphate . Kaohsiung J Med Sci 2013 ; 29 ( 11 ): 587 - 93 . doi: 10.1016/j.kjms.2013.04.004 http://dx.doi.org/10.1016/j.kjms.2013.04.004 .

Chen NX , O'Neill K , Akl NK , et al . Adipocyte induced arterial calcification is prevented with sodium thiosulfate . Biochem Biophys Res Commun 2014 ; 449 ( 1 ): 151 - 6 . doi: 10.1016/j.bbrc.2014.05.005 http://dx.doi.org/10.1016/j.bbrc.2014.05.005 .

Djuric P , Dimkovic N , Schlieper G , et al . Sodium thiosulphate and progression of vascular calcification in end-stage renal disease patients: a double-blind, randomized, placebo-controlled study . Nephrol Dial Transplant 2020 ; 35 ( 1 ): 162 - 9 . doi: 10.1093/ndt/gfz204 http://dx.doi.org/10.1093/ndt/gfz204 .

Saengpanit D , Chattranukulchai P , Tumkosit M , et al . Effect of sodium thiosulfate on arterial stiffness in end-stage renal disease patients undergoing chronic hemodialysis (sodium thiosulfate-hemodialysis study): a randomized controlled trial . Nephron 2018 ; 139 ( 3 ): 219 - 27 . doi: 10.1159/000488009 http://dx.doi.org/10.1159/000488009 .

Granata S , Dalla Gassa A , Tomei P , et al . Mitochondria: a new therapeutic target in chronic kidney disease . Nutr Metab (Lond) 2015 ; 12 : 49 . doi: 10.1186/s12986-015-0044-z http://dx.doi.org/10.1186/s12986-015-0044-z .

Cui L , Li Z , Chang X , et al . Quercetin attenuates vascular calcification by inhibiting oxidative stress and mitochondrial fission . Vascul Pharmacol 2017 ; 88 : 21 - 9 . doi: 10.1016/j.vph.2016.11.006 http://dx.doi.org/10.1016/j.vph.2016.11.006 .

Beazley KE , Eghtesad S , Nurminskaya MV . Quercetin attenuates warfarin-induced vascular calcification in vitro independently from matrix Gla protein . J Biol Chem 2013 ; 288 ( 4 ): 2632 - 40 . doi: 10.1074/jbc.M112.368639 http://dx.doi.org/10.1074/jbc.M112.368639 .

Chang XY , Cui L , Wang XZ , et al . Quercetin attenuates vascular calcification through suppressed oxidative stress in adenine-induced chronic renal failure rats . Biomed Res Int 2017 ; 2017 : 5716204 . doi: 10.1155/2017/5716204 http://dx.doi.org/10.1155/2017/5716204 .

Chen J , Hamm LL , Bundy JD , et al . Combination treatment with sodium nitrite and isoquercetin on endothelial dysfunction among patients with CKD: a randomized phase 2 pilot trial . Clin J Am Soc Nephrol 2020 ; 15 ( 11 ): 1566 - 75 . doi: 10.2215/CJN.02020220 http://dx.doi.org/10.2215/CJN.02020220 .

Suzuki S , Suzuki M , Hanafusa N , et al . Denosumab recovers aortic arch calcification during long-term hemodialysis . Kidney Int Rep 2021 , 6 : 605 - 12 . doi: 10.1016/j.ekir.2020.12.002 http://dx.doi.org/10.1016/j.ekir.2020.12.002 .

Kim H , Lee EJ , Woo S , et al . Effect of denosumab on bone health, vascular calcification, and health-related quality of life in hemodialysis patients with osteoporosis: a prospective observational study . J Clin Med 2024 , 13 . doi: 10.3390/jcm13051462 http://dx.doi.org/10.3390/jcm13051462 .

Al-Aly Z . Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opathy . Transl Res 2008 , 151 : 233 - 9 . doi: 10.1016/j.trsl.2007.12.005 http://dx.doi.org/10.1016/j.trsl.2007.12.005 .

Tiong MK , Smith ER , Toussaint ND , et al . Reduction of calciprotein particles in adults receiving infliximab for chronic inflammatory disease . JBMR Plus 2021 , 5 : e10497 . doi: 10.1002/jbm4.10497 http://dx.doi.org/10.1002/jbm4.10497 .

Zeng Q , Zhong Y , Yu X . Meta-analysis of the efficacy and safety of sevelamer as hyperphosphatemia therapy for hemodialysis patients . Ren Fail 2023 , 45 : 2210230 . doi: 10.1080/0886022X.2023.2210230 http://dx.doi.org/10.1080/0886022X.2023.2210230 .

Lioufas NM , Pascoe EM , Hawley CM , et al . Systematic review and meta-analyses of the effects of phosphate-lowering agents in nondialysis CKD . J Am Soc Nephrol 2022 , 33 : 59 - 76 . doi: 10.1681/ASN.2021040554 http://dx.doi.org/10.1681/ASN.2021040554 .

Hou YC , Zheng CM , Chiu HW , et al . Role of calcimimetics in treating bone and mineral disorders related to chronic kidney disease . Pharmaceuticals (Basel) 2022 , 15 . doi: 10.3390/ph15080952 http://dx.doi.org/10.3390/ph15080952 .

Mary A , Objois T , Brazier M , et al . Decreased monocyte calcium sensing receptor expression in patients with chronic kidney disease is associated with impaired monocyte ability to reduce vascular calcification . Kidney Int 2021 , 99 : 1382 - 91 . doi: 10.1016/j.kint.2021.01.026 http://dx.doi.org/10.1016/j.kint.2021.01.026 .

Zaslow SJ , Oliveira-Paula GH , Chen W . Magnesium and vascular calcification in chronic kidney disease: current insights . Int J Mol Sci 2024 , 25 . doi: 10.3390/ijms25021155 http://dx.doi.org/10.3390/ijms25021155 .

Ter Braake AD , Smit AE , Bos C , et al . Magnesium prevents vascular calcification in Klotho deficiency . Kidney Int 2020 , 97 : 487 - 501 . doi: 10.1016/j.kint.2019.09.034 http://dx.doi.org/10.1016/j.kint.2019.09.034 .

Bressendorff I , Hansen D , Schou M , et al . The effect of magnesium supplementation on vascular calcification in CKD: a randomized clinical trial (MAGiCAL-CKD) . J Am Soc Nephrol 2023 , 34 : 886 - 94 . doi: 10.1681/ASN.0000000000000092 http://dx.doi.org/10.1681/ASN.0000000000000092 .

Zhan Y , Zhang R , Li G . Effect of magnesium on vascular calcification in chronic kidney disease patients: a systematic review and meta-analysis . Ren Fail 2023 , 45 : 2182603 . doi: 10.1080/0886022X.2023.2182603 http://dx.doi.org/10.1080/0886022X.2023.2182603 .

Zhao L , Yang N , Song Y , et al . Effect of iron overload on endothelial cell calcification and its mechanism . Ann Transl Med 2021 , 9 : 1658 . doi: 10.21037/atm-21-5666 http://dx.doi.org/10.21037/atm-21-5666 .

Ye Y , Chen A , Li L , et al . Repression of the antiporter SLC7A11/glutathione/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification . Kidney Int 2022 , 102 : 1259 - 75 . doi: 10.1016/j.kint.2022.07.034 http://dx.doi.org/10.1016/j.kint.2022.07.034 .

Zhu K , Reiser J . ALKBH1 reduces DNA N6-methyladenine to allow for vascular calcification in chronic kidney disease . J Clin Invest 2021 , 131 . doi: 10.1172/JCI150966 http://dx.doi.org/10.1172/JCI150966 .

Ouyang L , Su X , Li W , et al . ALKBH1-demethylated DNA N6-methyladenine modification triggers vascular calcification via osteogenic reprogramming in chronic kidney disease . J Clin Invest 2021 , 131 . doi: 10.1172/JCI146985 http://dx.doi.org/10.1172/JCI146985 .

Li W , Feng W , Su X , et al . SIRT6 protects vascular smooth muscle cells from osteogenic transdifferentiation via RUNX2 in chronic kidney disease . J Clin Invest 2022 , 132 . doi: 10.1172/JCI150051 http://dx.doi.org/10.1172/JCI150051 .

Wang S , Tong M , Hu S , et al . The bioactive substance secreted by MSC retards mouse aortic vascular smooth muscle cells calcification . Biomed Res Int 2018 ; 2018 : 6053567 . doi: 10.1155/2018/6053567 http://dx.doi.org/10.1155/2018/6053567 .

Wang S , Hu S , Wang J , et al . Conditioned medium from bone marrow-derived mesenchymal stem cells inhibits vascular calcification through blockade of the BMP2-Smad1/5/8 signaling pathway . Stem Cell Res Ther 2018 ; 9 ( 1 ): 160 . doi: 10.1186/s13287-018-0894-1 http://dx.doi.org/10.1186/s13287-018-0894-1 .

Majesky MW , Dong XR , Regan JN , et al . Vascular smooth muscle progenitor cells: building and repairing blood vessels . Circ Res 2011 ; 108 ( 3 ): 365 - 77 . doi: 10.1161/CIRCRESAHA.110.223800 http://dx.doi.org/10.1161/CIRCRESAHA.110.223800 .

Kramann R , Goettsch C , Wongboonsin J , et al . Adventitial MSC-like cells are progenitors of vascular smooth muscle cells and drive vascular calcification in chronic kidney disease . Cell Stem Cell 2016 ; 19 ( 5 ): 628 - 42 . doi: 10.1016/j.stem.2016.08.001 http://dx.doi.org/10.1016/j.stem.2016.08.001 .

Angsubhakorn N , Kang N , Fearon C , et al . Contemporary management of severely calcified coronary lesions . J Pers Med 2022 ; 12 ( 10 ). doi: 10.3390/jpm12101638 http://dx.doi.org/10.3390/jpm12101638 .

Bulluck H , McEntegart M . Contemporary tools and devices for coronary calcium modification . JRSM Cardiovasc Dis 2022 ; 11 : 20480040221089760 . doi: 10.1177/20480040221089760 http://dx.doi.org/10.1177/20480040221089760 .

Secco GG , Ghione M , Mattesini A , et al . Very high-pressure dilatation for undilatable coronary lesions: indications and results with a new dedicated balloon . EuroIntervention 2016 ; 12 ( 3 ): 359 - 65 . doi: 10.4244/EIJY15M06_04 http://dx.doi.org/10.4244/EIJY15M06_04 .

Albiero R , Silber S , Di Mario C , et al . Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the Restenosis Cutting Balloon Evaluation Trial (RESCUT) . J Am Coll Cardiol 2004 ; 43 ( 6 ): 943 - 9 . doi: 10.1016/j.jacc.2003.09.054 http://dx.doi.org/10.1016/j.jacc.2003.09.054 .

Jujo K , Saito K , Ishida I , et al . Intimal disruption affects drug-eluting cobalt-chromium stent expansion: a randomized trial comparing scoring and conventional balloon predilation . Int J Cardiol 2016 ; 221 : 23 - 31 . doi: 10.1016/j.ijcard.2016.07.002 http://dx.doi.org/10.1016/j.ijcard.2016.07.002 .

Karimi Galougahi K , Patel S , Shlofmitz RA , et al . Calcific plaque modification by acoustic shock waves: intravascular lithotripsy in coronary interventions . Circ Cardiovasc Interv 2021 ; 14 ( 1 ): e009354 . doi: 10.1161/CIRCINTERVENTIONS.120.009354 http://dx.doi.org/10.1161/CIRCINTERVENTIONS.120.009354 .

Brinton TJ , Ali ZA , Hill JM , et al . Feasibility of shockwave coronary intravascular lithotripsy for the treatment of calcified coronary stenoses . Circulation 2019 ; 139 ( 6 ): 834 - 6 . doi: 10.1161/CIRCULATIONAHA.118.036531 http://dx.doi.org/10.1161/CIRCULATIONAHA.118.036531 .

Hill JM , Kereiakes DJ , Shlofmitz RA , et al . Intravascular lithotripsy for treatment of severely calcified coronary artery disease . J Am Coll Cardiol 2020 ; 76 ( 22 ): 2635 - 46 . doi: 10.1016/j.jacc.2020.09.603 http://dx.doi.org/10.1016/j.jacc.2020.09.603 .

Saito S , Yamazaki S , Takahashi A , et al . Intravascular lithotripsy for vessel preparation in severely calcified coronary arteries prior to stent placement - primary outcomes from the Japanese Disrupt CAD IV study . Circ J 2021 ; 85 ( 6 ): 826 - 33 . doi: 10.1253/circj.CJ-20-1174 http://dx.doi.org/10.1253/circj.CJ-20-1174 .

Tepe G , Brodmann M , Werner M , et al . Intravascular lithotripsy for peripheral artery calcification: 30-day outcomes from the randomized disrupt PAD Ⅲ trial . JACC Cardiovasc Interv 2021 ; 14 ( 12 ): 1352 - 61 . doi: 10.1016/j.jcin.2021.04.010 http://dx.doi.org/10.1016/j.jcin.2021.04.010 .

Lawton JS , Tamis-Holland JE , Bangalore S , et al . 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines . Circulation 2022 ; 145 ( 3 ): e18 - e114 . doi: 10.1161/CIR.0000000000001038 http://dx.doi.org/10.1161/CIR.0000000000001038 .

Genereux P , Lee AC , Kim CY , et al . Orbital atherectomy for treating de novo severely calcified coronary narrowing (1-year results from the pivotal ORBIT Ⅱ trial) . Am J Cardiol 2015 ; 115 ( 12 ): 1685 - 90 . doi: 10.1016/j.amjcard.2015.03.009 http://dx.doi.org/10.1016/j.amjcard.2015.03.009 .

Koster R , Kahler J , Brockhoff C , et al . Laser coronary angioplasty: history, present and future . Am J Cardiovasc Drugs 2002 ; 2 ( 3 ): 197 - 207 . doi: 10.2165/00129784-200202030-00006 http://dx.doi.org/10.2165/00129784-200202030-00006 .

Mohandes M , Rojas S , Moreno C , et al . Excimer laser in percutaneous coronary intervention of device uncrossable chronic total and functional occlusions . Cardiovasc Revasc Med 2020 ; 21 ( 5 ): 657 - 60 . doi: 10.1016/j.carrev.2019.08.022 http://dx.doi.org/10.1016/j.carrev.2019.08.022 .

Lee T , Shlofmitz RA , Song L , et al . The effectiveness of excimer laser angioplasty to treat coronary in-stent restenosis with peri-stent calcium as assessed by optical coherence tomography . EuroIntervention 2019 ; 15 ( 3 ): e279 - e88 . doi: 10.4244/EIJ-D-18-00139 http://dx.doi.org/10.4244/EIJ-D-18-00139 .

Kawashima H , Serruys PW , Hara H , et al . 10-year all-cause mortality following percutaneous or surgical revascularization in patients with heavy calcification . JACC Cardiovasc Interv 2022 ; 15 ( 2 ): 193 - 204 . doi: 10.1016/j.jcin.2021.10.026 http://dx.doi.org/10.1016/j.jcin.2021.10.026 .

Naggara O , Touze E , Beyssen B , et al . Anatomical and technical factors associated with stroke or death during carotid angioplasty and stenting: results from the endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial and systematic review . Stroke 2011 ; 42 ( 2 ): 380 - 8 . doi: 10.1161/STROKEAHA.110.588772 http://dx.doi.org/10.1161/STROKEAHA.110.588772 .